Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-β

Melanoma Research

Volumn 17, Issue 4, 2007, Pages 205-213

  Iida, Joji ^a   McCarthy, James B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Growth; Invasion; Matrix metalloproteinase; Transforming growth factor

Indexed keywords

COLLAGEN TYPE 1; INTERSTITIAL COLLAGENASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SKIN METASTASIS;

ANIMALS; CELL LINE, TUMOR; COLLAGEN TYPE I; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; MATRIX METALLOPROTEINASE 1; MELANOMA; MINK; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 34447534336     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3282a660ad     Document Type: Article

References (44)

1. Rudolph L, Matrisian L. Matrix metalloproteinases in remodeling of normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 1998; 3:177-189.
2. Valente P, Fassina G, Melchiori A, Masiello L, Cilli M, Vacca A, et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis [published erratum appears in Int J Cancer 1999 Jan 29; 80(3):485]. Int J Cancer 1998; 75:246-253.
3. Khokka R. Suppresion of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 1994; 86:299-304.
4. Ahonen M, Baker A, Kahari V. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998; 58:210-2315.
5. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001; 13:534-540.
6. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, Uehira M. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 1999; 17:177-181.
7. Hofmann U, Westphal J, Waas E, Zendman A, Cornelissen I, Ruiter D, van Muijen G. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 1999; 81:774-782.
8. MacDougall JR, Bani MR, Lin Y, Muschel RJ, Kerbel RS. 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer 1999; 80:504-512.
9. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM, Pyrhonen S. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 2002; 97:432-438.
10. Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115:337-344.
11. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000; 6:4823-4830.
12. Durko M, Navab R, Shibata HR, Brodt P. Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta 1997; 1356:271-280.
13. Benbow U, Schoenermark MP, Mitchell TI, Rutter JL, Shimokawa K, Nagase H, Brinckerhoff CE. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 1999; 274:25371-25378.
14. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005; 120:303-313.
15. Arribas J. Matrix metalloproteases and tumor invasion. N Engl J Med 2005; 352:2020-2021.
16. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 1988; 106:1659-1665.
17. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14:163-176.
18. Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 2002; 277:44061-44067.
19. Teti A, De Giorgi A, Spinella MT, Migliaccio S, Canipari R, Onetti Muda A, Faraggiana T. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro. Int J Cancer 1997; 72:1013-1020.
20. Janji B, Melchior C, Gouon V, Vallar L, Kieffer N. Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int J Cancer 1999; 83:255-262.
21. Iida J, Wilhelmson KL, Price MA, Wilson CM, Pei D, Furcht LT, McCarthy JB. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol 2004; 122:167-176.
22. Faassen A, Schrager J, Klein D, Oegema T, Couchman J, McCarthy J. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 1992; 116:521-531.
23. Kang T, Yi J, Yang W, Wang X, Jiang A, Pei D. Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice. FASEB J 2000; 14:2559-2568.
24. Dong F, Wu HB, Hong J, Rechler MM. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells. J Cell Physiol 2002; 190:63-73.
25. Lehti K, Valtanen H, Wickstrom S, Lohi J, Keski-Oja J. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 2000; 275:15006-15013.
26. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114:33-45.
27. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272:2446-2451.
28. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001; 189:1-13.
29. Komesli S, Vivien D, Dutartre P. Chimeric extracellular domain type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist. Eur J Biochem 1998; 254:505-513.
30. Hornebeck W, Emonnard H, Monboisse J, G B. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 2002; 12:231-241.
31. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999; 80:733-743.
32. Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M, Roby JD, Santoro SA, Parks WC. Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem 2001; 276:29368-29374.
33. O'Hare MC, Curry VA, Mitchell RE, Cawston TE. Stabilisation of purified human collagenase by site-directed mutagenesis. Biochem Biophys Res Commun 1995; 216:329-337.
34. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89:1260-1270.
35. Pasternak RD, Hubbs SJ, Caccese RG, Marks RL, Conaty JM, DiPasquale G. Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes. Clin Immunol Immunopathol 1986; 41:351-367.
36. Allen DL, Teitelbaum DH, Kurachi K. Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am J Physiol Cell Physiol 2003; 284:C805-C815.
37. Zygmunt M, Hahn D, Kiesenbauer N, Munstedt K, Lang U. Invasion of cytotrophoblastic (JEG-3) cells is up-regulated by interleukin-15 in vitro. Am J Reprod Immunol 1998; 40:326-331.
38. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med 2000; 6:391-407.
39. Benbow U, Tower GB, Wyatt CA, Buttice G, Brinckerhoff CE. High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. J Cell Biochem 2002; 86:307-319.
40. Wyatt CA, Geoghegan JC, Brinckerhoff CE. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res 2005; 65:11101-11108.
41. Crabbe T, O'Connell JP, Smith BJ, Docherty AJ. Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A. Biochemistry 1994; 33:14419-14425.
42. Rodeck U, Nishiyama T, Mauviel A. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells. Cancer Res 1999; 59:547-550.
43. Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, et al. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res 2007; 67:2317-2324.
44. Javelaud D, Delmas V, Moller M, Sextius P, Andre J, Menashi S, et al. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene 2005; 24:7624-7629.